Cartel Intel – interview with FTI Consulting Senior Managing Director Ashley Brickles

In advance of the next edition of Cartel Intel, Brussels Partner Daniel Vowden sat down with Ashley Brickles, Senior Managing Director at FTI Consulting, to discuss the changed nature of dawn raid inspections, the new tools and technologies available to antitrust authorities, and the precautions businesses should sensibly be taking to mitigate risks and maximise … Read more

HSF Competition team launches new “CRTea” podcast series

Welcome to our brand new “CRTea” podcast series, which will bring you the latest developments in Competition, Regulatory and Trade (“CRT”) law from across EMEA and beyond. In this rapidly-evolving regulatory landscape, these regular podcasts will provide practical insights from our network of specialists (and maybe some special guests along the way) in a digestible, … Read more

Hong Kong Competition Law Enforcement Updates: A Tiger Ready to Pounce

The Hong Kong Competition Commission celebrated the sixth full year of the Competition Ordinance in December 2021, after an increase of enforcement activities and policy making efforts during 2021. 2022 has started with a flurry of activity. On 18 January 2022, the Commission conducted a joint dawn raid in the building maintenance sector with the … Read more

A new dawn for cartel enforcement? Competition authorities across Europe resume unannounced dawn raid inspections

On 22 June 2021 the European Commission (“Commission”) revealed that it had carried out surprise inspections at the German premises of a company active in the clothing sector, suspected of infringing competition rules.  This was the first unannounced inspection, or “dawn raid”, conducted by the Commission since the COVID-19 pandemic first struck Europe in March … Read more

China’s SAMR Continues Focus on Pharma Sector Amid Covid-19 Outbreak, Fining API Distributors Over RMB300m for Abuse of Dominance

On 9 April 2020, China’s State Administration for Market Regulation (SAMR) fined 3 pharmaceutical companies for abuse of dominance in the distribution of injectable calcium gluconate Active Pharmaceutical Ingredient (API). The three companies were found to be in breach of the PRC’s Anti-Monopoly Law (the AML) between August 2015 and December 2017, by selling at … Read more